A prospective study of clinico-pathological features of epithelial ovarian cancer in Pakistan

Journal of the Pakistan Medical Association

Volumn 52, Issue 4, 2002, Pages 155-158

  Malik, I A ^a  

^a National Cancer Institute   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; DEMOGRAPHY; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MIDDLE AGED; OVARY TUMOR; PAKISTAN; PATHOLOGY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; DEMOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PAKISTAN; PROSPECTIVE STUDIES; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 0036527916     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1973-1997. Bethesda, MD, National Cancer Institute, 2000.
2. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 18 major cancers in 1985. Int. J. Cancer, 1993;54:594-606.
3. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer Statistics, 2001. CA. Cancer, J. Clin., 2001;15:15-36.
4. Young RC, Perez CA, Hoskins WJ. Cancer of the ovary, in De Vita Jr, Hellman SA (eds): Cancer principles and practice of Oncology (ed. 4). Philadephia: Lippncott, 1993,pp.1126-63.
5. Malik I, Khan W, Khan Z. Pattern of malignant tumors observed in a University hospital: A retrospective analysis. J. Pak. Med. Assoc., 1998;48:120-122.
6. Bhurgri Y, Bhurgri A, Hassan SH, et al. Cancer incidence in Karachi, Pakistan: first results from Karachi Cancer Registry. Int. J. Cancer, 2000;85:325-29.
7. Yamashita Y, Sagawa T, Fujimoto T, et al. BRCA1 mutation testing for Japanese patients with ovarian ovarian cancer in breast cancer screening Breast Cancer Res. Treat, 1999;58:11-17.
8. Chen Y, Wu PC, Lang JH, et al. Risk factors for epithelial ovarian cancer in Beijing, China. Int. J. Epidemiol ,1992;21:23-29.
9. Nandakumar A, Anantha N, Dhar M, et al. A case-control investigation on cancer of the ovary in Banglore, India. Int. J. Cancer, 1995;03:361-65.
10. Chaitchik S, Ron IG, Baram A, et al. Population differences in ovarian cancer in Israel. Gynecol. Oncol.,1985;21:155-60.
11. Herrinton LJ, Stanford JL, Schwartz SM, et al. Ovarian cancer incidence among Asian migrants to the United States and their descendents. J. Natl. Cancer, Inst., 1994;86:1336-39.
12. Bewtra C, Waston P, Comway T, et al. Hereditary ovarian cancer: a clinicopathological study. Int. J. Gynecol. Pathol., 1992;11:130-87.
13. Chang J, Fryatt I, Ponder B, et al. A Matched control study of familial epithelial ovarian cancer; patient characteristics, response to chemotherapy and outcome. Ann. Oncol., 1995;6:80-82.
14. Moslehi R, Solehdin F, Malik I, et al. Analysis of BRCA1 and BRCA2 mutations in a Pakistani Family with hereditary breast and ovarian cancer syndrome Am. J. Med. Genet., 1998;78:386-87.
15. Bittles AH, Grant JC, Shami SA. Consangunity as a determinant of reproductive behavior and mortality in Pakistan. Int. J. Epidemiol., 1993;22:463-67.
16. Wahab A, Ahmed M. Biosocial perspective of consanguineous marriages in rural and urban Swat, Pakistan. J. Biosoc. Sci., 1996;28:305-13.
17. Charak BS, Agarwal S, Gopal R, et al. Cisplatin-based chemotherapy in advanced ovarian cancer: initial experience in an Indian set-up. Indian J. Cancer, 1989;26:85-91.
18. Singh P, Arunachalam I, Singh P, et al. Ovarian cancer in Oriental women from Singapore: disease pattern and survival. Int. Surg., 1990;75:115-22.
19. Malik I, Khan Z, Khan W, et al. Continuous infusion of ifosfamide and cisplatin as first-line cancer therapy of patients with sub-optimally stage III-IV epithelialovarian cancer. Int. J. Gyne. Cancer, 1998;8:138-43.
20. Malik I. An open label evaluation of topotecan in patients with relapsed or refractory epithelial ovarian cancer-single institution experience in a developing country. Int. J. Gynecol. Cancer, 2000;10:443-48.